TGTX TG Therapeutics Inc
17,829
$18.31
$0.99
(5.72%)
| Watchers | 17,829 |
| 52-Wk Low | $6.46 |
| 52-Wk High | $31.81 |
| Market Cap | $2.68B |
| Volume | 1.78M |
| 52-Wk High | $31.81 |
| 52-Wk Low | $6.46 |
TG Therapeutics (TGTX, $14.77) price may climb as it broke lower Bollinger Band on Apr 01, 2024Tickeron - Stocks • about 1 month ago
This price move could be a signal that TGTX may jump back above the lower band and head toward the middle band. Traders may consider buying the stock or exploring call options...
Share to Feed
This is a signal that TGTX's price trend could be reversing, and it may be an opportunity to buy the stock or explore call options...
TG Therapeutics, Inc. (NASDAQ:TGTX Get Free Report) Director Laurence N. Charney sold 22,000 shares of TG Therapeutics stock in a transaction on Tuesday, March 12th. The shares were sold at...
This is a Bearish indicator signaling TGTX's price could decline from here. Traders may explore shorting the stock or put options...
Related Stocks: TGTX...
Shares of TG Therapeutics, Inc. (NASDAQ:TGTX Get Free Report) dropped 3.9% on Friday . The stock traded as low as $17.11 and last traded at $17.30. Approximately 1,522,506 shares changed...
NEW YORK, March 08, 2024 (GLOBE NEWSWIRE) -- TG Therapeutics, Inc. (NASDAQ: TGTX), today announced the schedule of data presentations highlighting data from the ULTIMATE I & II Phase 3 trials...
This is a signal that TGTX's price could be shifting from an uptrend to a downtrend. Traders may consider selling the stock or exploring put options...
TG Therapeutics, Inc. (NASDAQ:TGTX Free Report) Equities researchers at B. Riley increased their Q1 2024 EPS estimates for TG Therapeutics in a research report issued to clients and...
TG Therapeutics, Inc. (NASDAQ:TGTX Free Report) Stock analysts at HC Wainwright reduced their Q1 2024 EPS estimates for TG Therapeutics in a research report issued on Wednesday...